Perrigo Begins
Shipping Famotidine Complete

August 12, 2008
Text Size:

ALLEGAN — Perrigo Co. this week began shipping store branded Famotidine Complete chewable tablets to customers across the United States under their store brand labels. The Perrigo product is the generic equivalent of Pepcid Complete, a product used for heartburn associated with acid indigestion. Pepcid Complete has estimated annual sales of approximately $100 million. 

Perrigo won a patent challenge for Famotidine Complete against Pepcid Complete, which is marketed by Johnson & Johnson — Merck Consumer Pharmaceuticals.

"This is another example of Perrigo's investment in new products that are making quality health care more affordable to American consumers," said President and CEO Joseph C. Papa. "Famotidine Complete is an important new store brand product in the gastrointestinal segment for our retail and wholesale customers and enables them to provide significant savings for the consumer."     

Editor's Picks

Comments powered by Disqus